Published in Medical Letter on the CDC and FDA, December 13th, 2009
"Numerous case series and cardiac literature parallels suggest that acute stenting may yield high revascularization levels with low associated morbidity. We therefore conducted a Food and Drug Administration-approved prospective pilot trial to evaluate the safety of intracranial stenting for acute ischemic stroke. Eligibility criteria included presentation <= 8 hours after stroke onset, age 18 years or older, National Institutes of Health...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA